tirzepatide or retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Mounjaro: triple agonist
Description
Insurance approval for GLP-1 receptor agonists for weight loss typically requires BMI 30 kg/m OR BMI 27 kg/m with at least one weight-related comorbidity...
A Retatrutide dosing chart starts at 2 mg weekly and escalates to 24 mg
Book now for a door-to-door adventure with Daytrip!
Learn how to spot telogen effluvium, protect protein and nutrients, and use proven treatments to stop shedding and restart healthy growth on GLP-1s
